Invest in

Biotech Breakthroughs

7.6%
1.1%
0.6%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
7.6%
1.1%
0.6%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
34.3% Cancer 7.6%
21.2% Amgen Inc. AMGN 13.3%
11.1% Celgene Corporation CELG 9.5%
1.3% Medivation Inc. MDVN 78.9%
0.7% Spectrum Pharmaceuticals Inc. SPPI 23.0%
17.8% Other Diseases 23.9%
6.3% Regeneron Pharmaceuticals Inc. REGN 25.3%
4.5% Alexion Pharmaceuticals Inc. ALXN 25.6%
3.6% Vertex Pharmaceuticals Incorporated VRTX 25.9%
2.2% United Therapeutics Corporation UTHR 22.7%
1.3% Repligen Corporation RGEN 8.2%
17.2% Autoimmune Disorders 6.9%
10.9% Biogen Inc. BIIB 2.9%
2.7% BioMarin Pharmaceutical Inc. BMRN 25.9%
2.6% Incyte Corporation INCY 26.2%
0.9% ACADIA Pharmaceuticals Inc. ACAD 11.2%
16.0% Infectious Diseases 23.3%
13.9% Gilead Sciences Inc. GILD 23.7%
1.3% Opko Health Inc. OPK 20.7%
0.7% Emergent Biosolutions Inc. EBS 20.2%
14.7% Research & Diagnostics 2.0%
5.2% Quintiles Transnational Holdings Inc. Q 3.2%
4.3% Qiagen N.V. QGEN 0.4%
4.3% Illumina Inc. ILMN 13.4%
1.0% Meridian Bioscience Inc. VIVO 10.0%

Quotes delayed 15 mins. Currently Aug 29, 2016 1:17:05 AM. Fields are marked with -- when data is unavailable.